- Report
- October 2024
- 180 Pages
Global
From €2127EUR$2,400USD£1,849GBP
- Report
- May 2025
- 186 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 186 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 186 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- April 2025
- 200 Pages
Global
From €2207EUR$2,490USD£1,919GBP
- Report
- March 2025
- 317 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- March 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- July 2025
- 177 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- July 2025
- 340 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- April 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- July 2025
- 278 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- August 2024
- 141 Pages
Global
From €2658EUR$2,999USD£2,311GBP
- Report
- June 2025
- 185 Pages
Global
From €3390EUR$3,825USD£2,948GBP
€3989EUR$4,500USD£3,468GBP
- Report
- March 2025
- 180 Pages
Global
From €3390EUR$3,825USD£2,948GBP
€3989EUR$4,500USD£3,468GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1108EUR$1,250USD£963GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,156GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2472EUR$2,789USD£2,149GBP
- Report
- June 2025
- 221 Pages
Global
From €4427EUR$4,995USD£3,849GBP

The Estrogen Receptor (ER) market is a segment of the Endocrine and Metabolic Disorders Drugs market. ER drugs are used to treat a variety of conditions, including menopausal symptoms, osteoporosis, and breast cancer. ER drugs work by binding to the estrogen receptor, which is found in many tissues throughout the body. This binding triggers a cascade of events that can lead to the desired therapeutic effect. ER drugs are typically administered orally, as a topical cream, or as an injection.
ER drugs are typically prescribed to postmenopausal women, as well as to men with certain conditions. The market for ER drugs is expected to grow in the coming years, driven by an aging population and increasing awareness of the importance of hormone therapy.
Some companies in the ER market include Pfizer, Novartis, Merck, and AstraZeneca. Show Less Read more